SRPT
#1990
Sarepta Therapeutics, Inc. - Common Stock
18.4 9 USD
-0.02%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.75%
Monthly Change
+17.92%
6 month change
-18.44%
Year Change
-5.28%
Previous Close
18.8 2
Open
18.8 5
Low
18.3 6
High
18.8 5
Volume
420
Financials
- Market Capitalization 1.95 B
- Employee 835
- Founded 1980
- CEO Douglas S. Ingram
- Website www.sarepta.com
- Headquarter Delaware, United States
- FIGI BBG000BCJ161
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.02
Price to sales ratio
0.98
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1987 |  NUVB Nuvation Bio Inc. Class A Common Stock | 5.87 USD | +1.91% | +0.86% | +16.70% | +169.27% | 2.04 B USD | ||
| 1989 |  ABCL AbCellera Biologics Inc. - Common Shares | 6.63 USD | +1.69% | -15.97% | +21.21% | +50.34% | 2.02 B USD | ||
| 1991 |  SION Sionna Therapeutics, Inc. - Common Stock | 43.51 USD | -1.00% | -0.62% | +19.07% | +10.60% | 1.96 B USD | ||
| 2000 |  VRDN Viridian Therapeutics, Inc. - Common Stock | 19.10 USD | +0.58% | -2.05% | +15.20% | -14.92% | 1.97 B USD |
Frequently asked questions about Sarepta Therapeutics, Inc. - Common Stock
What is the Sarepta Therapeutics, Inc. - Common Stock stock price today?
The current price of Sarepta Therapeutics, Inc. - Common Stock (SRPT) is 18.49. Over the past 24 hours, the stock has changed by -1.75%. Follow the SRPT chart for real-time price dynamics.
What is the stock ticker of Sarepta Therapeutics, Inc. - Common Stock?
Sarepta Therapeutics, Inc. - Common Stock trades under the ticker SRPT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Sarepta Therapeutics, Inc. - Common Stock stock going up?
SRPT has changed by -2.12% over the last week, +17.92% over the last month, and -5.28% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Sarepta Therapeutics, Inc. - Common Stock net income for the last quarter?
Sarepta Therapeutics, Inc. - Common Stock reported net income of 330.96 M for the last quarter. The previous quarter showed -412.23 M, which means net income changed by +180.29%.
How many employees does Sarepta Therapeutics, Inc. - Common Stock have?
As of the latest available data, Sarepta Therapeutics, Inc. - Common Stock has 835 employees. Workforce size can provide additional context about the company's scale and operations.
What is Sarepta Therapeutics, Inc. - Common Stock EBITDA?
Sarepta Therapeutics, Inc. - Common Stock EBITDA is 369.03 M, and its EBITDA margin is 50.5%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Sarepta Therapeutics, Inc. - Common Stock stock?
You can buy Sarepta Therapeutics, Inc. - Common Stock (SRPT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Sarepta Therapeutics, Inc. - Common Stock stock?
Investing in Sarepta Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SRPT chart and related analysis on metatrader.com as part of your research.